Verition Fund Management
TARO

Verition Fund Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Verition Fund Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,647
Closed -$281K – 3360
2024
Q1 		$281K Buy
6,647
+1,025
+18% +$43.2K ﹤0.01% 2324
2023
Q4 		$235K Sell
5,622
-61,962
-92% -$2.28M ﹤0.01% 1932
2023
Q3 		$2.55M Buy
+67,584
New +$2.54M 0.03% 684

Other funds holding TARO

KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $1.65B AUM 25.75% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Verition Fund Management's TARO Position: Q2 2024 in Review

Verition Fund Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 6,647 shares — an estimated $281K sold.

Verition Fund Management first reported a position in TARO in Q3 2023 and held it in 3 quarters. The position peaked at $2.55M in Q3 2023. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • Verition Fund Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • Verition Fund Management sold 6,647 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $281K.
  • Verition Fund Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2023 and held it in 3 quarters.
  • Verition Fund Management's Taro Pharmaceutical Industries Ltd. position peaked at $2.55M in Q3 2023.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on Verition Fund Management's 13F filing for Q2 2024, filed 14 Aug 2024.